COVID-19 On March 11, 2020, the World Health Organization declared the COVID‐19 outbreak (caused by SARS‐CoV‐2) a pandemic. Communication from the CDC, SMFM and ACOG to obstetric care providers about COVID‐19 and how best to advise and manage pregnant patients is imperative and rapidly evolving. With regard to COVID‐19 infection in pregnancy and antenatal [...]
Pregnancy and the COVID-19 Vaccine At New Jersey Perinatal Associates, we want to ensure that all of our patients are fully informed about the COVID-19 pandemic, as well as the development of the COVID-19 vaccine. The US Food and Drug Administration has issued emergency use authorization (EUA) of two vaccines to prevent COVID-19, which [...]
Dr. Kathy Matthews is one of the newest members at New Jersey Perinatal Associates. She grew up in Ontario, Canada before moving to the United States, and earned her medical degree from George Washington School of Medicine & Health Sciences. She went on to complete her Obstetrics & Gynecology residency at Icahn School of [...]
Covid-19 Updates Experts are learning more every day about the new coronavirus that causes COVID-19. The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) are following the situation closely and frequently update their websites with guidelines and recommendations. Per the New Jersey Department of Health, as of [...]
Due to the unprecedented circumstances of the current COVID-19 global pandemic, New Jersey Perinatal Associates’ recommendations for ultrasound and antenatal testing follow-up are changing to limit patient contact and decrease the spread of disease. Our current guidelines are based on the recent AJOG article by Boelig, et al. (Boelig RC, Saccone G, Bellussi F, [...]
Pregnancy and Coronavirus NJPA is committed to ensuring the safety of our patients and employees, particularly among the recent concern and outbreak of the COVID-19 virus. NJPA continues to adhere to the latest guidance from the Centers for Disease Control and Prevention (CDC), the Society of Maternal Fetal Medicine (SMFM), the American College of [...]
In 2020, we have seen the emergence of Coronavirus, a new virus that has led to a global public health emergency. At NJPA, we want to take the time to inform you about Coronavirus. Initial research shows that Coronavirus does not transfer to the fetus during pregnancy or delivery, nor does it enter breast [...]
In this newsletter… Update on Prophylactic 17-OHPC (Makena) Update on fetal echocardiogram indications Meet our perinatologist Update on Prophylactic 17 OH Progesterone Caproate Recurrent spontaneous preterm birth (sPTB) is a major public health problem. It is defined as spontaneous delivery prior to 37 weeks of gestation and is associated with significant adverse outcomes. The strongest [...]
In this newsletter… Elective Induction of Labor in Low-Risk Nulliparous Women at Term: The ARRIVE Trial Centers for Disease Control and Prevention (CDC) updates Zika virus and pregnancy recommendations Meet our perinatologist Elective Induction of Labor at Term Historically, elective induction of labor has been regarded as harmful with a possible increased risk of cesarean [...]
In this newsletter… Perinatal Hepatitis B Prevention Genetics Corner Meet our Perinatologist Perinatal Hepatitis B Prevention Between 800,000-1.4 million people in the United States and more than 240 million people worldwide are infected with hepatitis B virus (HBV). Specific to pregnancy, an estimated prevalence of 0.7-0.9% for chronic HBV infection among pregnant women in the [...]
